Assessment of bone marrow infiltration in B-cell non-Hodgkin's lymphoma (NHL).
作者信息
Dorey E L, Outram S V, Holder A, Rohatiner A Z, Cotter F E, Deane M, Stansfeld A G, Lister T A, Horton M A
机构信息
Imperial Cancer Research Fund, Department of Medical Oncology, London, UK.
出版信息
Br J Cancer. 1989 May;59(5):772-4. doi: 10.1038/bjc.1989.161.
Abstract
摘要
相似文献
1
Assessment of bone marrow infiltration in B-cell non-Hodgkin's lymphoma (NHL).B细胞非霍奇金淋巴瘤（NHL）中骨髓浸润的评估。
Br J Cancer. 1989 May;59(5):772-4. doi: 10.1038/bjc.1989.161.
2
3
[Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].112例淋巴系统恶性疾病的骨髓免疫表型分析
Ai Zheng. 2007 Apr;26(4):418-22.
4
Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's disease.非霍奇金淋巴瘤或霍奇金病患者体内循环的CD20和CD52
Br J Haematol. 2003 Dec;123(5):850-7. doi: 10.1046/j.1365-2141.2003.04683.x.
5
Activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.B 细胞非霍奇金淋巴瘤中的激活与分化抗原表达
J Pathol. 1988 Mar;154(3):209-22. doi: 10.1002/path.1711540304.
6
Prognostic significance of activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.
J Pathol. 1989 Nov;159(3):211-20. doi: 10.1002/path.1711590307.
7
Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.非霍奇金淋巴瘤的骨髓受累：淋巴结与骨髓形态学不一致的临床意义。内布拉斯加淋巴瘤研究组
J Clin Oncol. 1990 Jul;8(7):1163-72. doi: 10.1200/JCO.1990.8.7.1163.
8
Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification.非霍奇金淋巴瘤的免疫组织化学分型——工作分类法与世界卫生组织分类法的比较
Indian J Pathol Microbiol. 2006 Apr;49(2):203-7.
9
Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin sections.
J Pathol. 1990 Mar;160(3):239-43. doi: 10.1002/path.1711600310.
10
Demonstration of clonal selection in a child with non-Hodgkin's lymphoma.一名非霍奇金淋巴瘤患儿克隆选择的证明。
Cancer. 1989 Jun 1;63(11):2130-3. doi: 10.1002/1097-0142(19890601)63:11<2130::aid-cncr2820631110>3.0.co;2-9.
本文引用的文献
1
Expression of cell surface markers after human B lymphocyte activation.人B淋巴细胞活化后细胞表面标志物的表达。
Proc Natl Acad Sci U S A. 1981 Jun;78(6):3848-52. doi: 10.1073/pnas.78.6.3848.
2
3
4
Characterization of a human B lymphocyte-specific antigen.一种人类B淋巴细胞特异性抗原的特性描述。
J Immunol. 1980 Oct;125(4):1678-85.
5
Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma.抗B1单克隆抗体与补体疗法用于复发性B细胞非霍奇金淋巴瘤的自体骨髓移植治疗
Lancet. 1984 Aug 25;2(8400):427-31. doi: 10.1016/s0140-6736(84)92907-6.
6
Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.
Cancer Res. 1985 Feb;45(2):499-503.
7
Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.恶性淋巴瘤中t(14;18)染色体易位的分子分析。
N Engl J Med. 1987 Nov 5;317(19):1185-9. doi: 10.1056/NEJM198711053171904.
8
Lymphocyte subsets in normal bone marrow.正常骨髓中的淋巴细胞亚群。
Blood. 1986 Jun;67(6):1600-6.
9
Circulating lymphoma cells in patients with B & T non-Hodgkin's lymphoma detected by immunoglobulin and T-cell receptor gene rearrangement.通过免疫球蛋白和T细胞受体基因重排检测B和T非霍奇金淋巴瘤患者的循环淋巴瘤细胞。
Br J Cancer. 1987 Aug;56(2):147-52. doi: 10.1038/bjc.1987.174.
Zotero 插件